The researcher is interested in the pathologies of the basal ganglia and the movement disorders they cause, both pathophysiologically and therapeutically, from a perspective that is both fundamental and clinical. He develops animal models to characterize the central mechanisms contributing to the appearance of dyskinesias. 

He also conducts clinical trials in subjects suffering from parkinsonian syndrome and subjects with orofacial dyskinesia.  

Main ongoing projects:  

• Study of non-motor and imaging parameters in elderly schizophrenic subjects with late parkinsonism.
• Pharmacological and molecular characterization of tardive oral dyskinesia in an animal model. 
• Randomized, double-blind, placebo-controlled trial evaluating the efficacy of omega-3 supplements fortified with docosahexaenoic acid on tardive dyskinesia. 
• Exploratory study on the correlation between oral health indices and the intensity of the expression of tardive oral dyskinesia in patients taking neuroleptics. 
• Sensory integration and motor adaptation in Parkinson's disease. 
• Impact of co-morbidity on cognition and behavior in adults and children with Gilles-de-la-Tourette syndrome.